Key Announcement from 2seventy bio
2seventy bio, Inc. (Nasdaq: TSVT) is gearing up to release its financial results for the third quarter of 2024. This significant disclosure is set to take place on an upcoming Tuesday, providing essential insights into the company’s financial health and future directions. Investors and stakeholders are encouraged to tune in to the conference call scheduled for 8:00 a.m. ET.
Participate in the Conference Call
The conference call will be accessible through a live webcast available on the Investors and Media sections of 2seventy bio's official website. For those wishing to engage further, there will be opportunities to ask questions during the call. Interested participants should ensure they register ahead of time to obtain the dial-in numbers and join instructions. It is advisable to log in approximately ten minutes before the start of the event to facilitate a smooth experience.
Engagement at Healthcare Innovation Conference
In addition to the financial results announcement, members of the management team are slated to participate in the prestigious Healthcare Innovation Conference organized by Guggenheim. This event will occur in Boston and is designed to spotlight groundbreaking developments in healthcare.
Details of the Conference
The conference is scheduled for Wednesday at 10:00 a.m. ET, where 2seventy bio will have the opportunity to share its innovations and engage with key stakeholders in the healthcare industry. This participation aligns with the company’s mission to expedite the translation of scientific insights into viable therapies for patients.
Live Webcast and Replays
The psychic of these events extends to public engagement, as a live webcast of the fireside chat at the conference will be available on the company website. Those who miss the live event can breathe easy knowing that replays will be accessible on 2seventy bio’s site for up to 30 days post-event.
About 2seventy bio
2seventy bio’s name embodies their commitment to making time matter in the fight against cancer. With a focus on high-speed innovation, they harness the power of the human immune system to create effective treatments, including the much-anticipated FDA-approved CAR T cell therapy aimed at multiple myeloma. Their strategy is guided by a deep-rooted dedication to authenticity and mission-driven actions, striving to make a positive impact on the lives of their patients.
Staying Informed and Connected
For ongoing updates about the company and its developments, interested parties can visit the 2seventy bio website. Additionally, following 2seventy bio on social media platforms like X (formerly Twitter) and LinkedIn offers valuable insights into their innovations and the broader mission.
Frequently Asked Questions
What is the date of the Q3 2024 financial results announcement?
The announcement is scheduled for a Tuesday in November 2024.
How can I join the conference call?
You can access the conference call via the company’s Investors and Media page on its website.
Where will the Guggenheim Healthcare Innovation Conference be held?
The conference will take place in Boston, Massachusetts.
Will there be a webcast for the fireside chat?
Yes, a live webcast will be available, and it will also be archived for 30 days after the event.
What is the mission of 2seventy bio?
The company aims to expedite cancer treatment innovation to provide patients with more time and better outcomes.